Pfizer is recalling an additional 38,000 bottles of the cholesterol-fighting drug Lipitor after reports of an odor related to the packaging bottles, the drug company said in a statement.
The recall will affect Lipitor 40 mg tablets (atorvastatin calcium) distributed in the United States. The company said the bottles were supplied by a third-party manufacturer.
"We have thoroughly evaluated the root cause, which is episodic exposure of the bottles to low levels of TBA (tribromoanisole) as they are shipped or stored," Pfizer said. The company said the rate of odor complaints was fewer than three per million bottles.
Earlier this year, Pfizer recalled more than 190,000 bottles of Lipitor due to similar odor-related complaints.